OrbiMed Israel BioFund GP Limited Partnership, 10% Owner at Chemomab Therapeutics Ltd. (CMMB), sold 673,800 shares at $4.51 ($2.4M) on 2023-01-03, disclosed to the SEC on 2023-01-05.
Open-market sale of $2.4M CMMB by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.34 | 266,376 | $890K | 36.8% |
| 2 | $3.34 | 266,376 | $890K | 36.8% |
| 3 | $4.51 | 70,524 | $318K | 13.2% |
| 4 | $4.51 | 70,524 | $318K | 13.2% |
| Total | $3.58 avg | 673,800 | $2.4M | 100% |
| Filing → |
| NVUS | BUY | 2019-05-06 | $4.0M | — | Filing → |